Archive: 29/12/2020

Phase 3 trials begin for Novavax vaccine in US, Mexico

Clinical trials to determine the safety and efficacy of a COVID-19 vaccine candidate from American biotech company Novavax have begun in the United States and Mexico, the US National Institutes of Health (NIH) announced Monday.

page 3 from 5